List of Author-it Docuvera Customers
Palmerston North, 4410,
New Zealand
Since 2010, our global team of researchers has been studying Author-it Docuvera customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Author-it Docuvera for Document Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Author-it Docuvera for Document Management include: Eli Lilly, a United States based Life Sciences organisation with 50605 employees and revenues of $65.18 billion, Boehringer Ingelheim, a Germany based Life Sciences organisation with 54500 employees and revenues of $28.94 billion and many others.
Contact us if you need a completed and verified list of companies using Author-it Docuvera, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Author-it Docuvera customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Boehringer Ingelheim | Life Sciences | 54500 | $28.9B | Germany | Author-it Software | Author-it Docuvera | Document Management | 2020 | n/a |
In 2020, Boehringer Ingelheim implemented Author-it Docuvera for Document Management to enable medical authors to assemble clinical and regulatory documents from pre-approved component content. The deployment focused on clinical and regulatory documentation across Germany and Europe, aiming to standardize component-level content and improve authoring consistency for regulated submissions.
Author-it Docuvera was configured to support component authoring, a pre-approved content library, content governance workflows, and version control for clinical and regulatory document production. The platform introduction addressed manual copy and paste desktop workflows by providing a governance-ready component authoring platform for clinical and regulatory authors, and it was positioned to improve efficiency and compliance while reducing document update time.
|
 |
Eli Lilly | Life Sciences | 50605 | $65.2B | United States | Author-it Software | Author-it Docuvera | Document Management | 2020 | n/a |
In 2020, Eli Lilly implemented Author-it Docuvera to move Global Medical Information to component authoring. The Author-it Docuvera Document Management deployment targeted medical and medical information processes across Lilly's global operations, led from the United States, with an explicit focus on regulatory-facing documentation to improve authoring speed and content consistency.
The implementation was configured around component authoring and reuse management, with structured content and content assembly capabilities to support modular documentation. Configuration work included version control and review workflow orchestration to align medical writing processes with regulatory requirements and to standardize content production across teams.
Operational coverage concentrated on Global Medical Information and adjacent medical information authoring workflows, rolled out across Lilly's global sites and US operations. The deployment supported medical information and regulatory content creation, centralizing component libraries to enable reuse across product and regulatory documentation streams.
Governance was strengthened through centralized component libraries and controlled review cycles, which standardized terminology and reduced variability in regulatory-facing outputs. Eli Lilly reported roughly 65% reuse of components in the first year and later reported reuse levels above 80% in production, demonstrating sustained adoption of component-based Document Management practices with Author-it Docuvera.
|
Buyer Intent: Companies Evaluating Author-it Docuvera
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||